💡 Bottom Line
Embody is one of the only providers offering oral tirzepatide in a chewable gum format — a genuine option for patients who want the dual-agonist benefits of tirzepatide without injections. The $149 first month is an excellent entry point, but the $299/month ongoing price is above the market average. Best for: needle-averse patients who want tirzepatide specifically.

Embody stands out in the crowded GLP-1 telehealth market for one reason: they offer compounded tirzepatide as an oral chewable gum. In a market dominated by injectable medications, that's a meaningful differentiator — especially for the estimated 20–25% of patients who avoid GLP-1 treatment due to needle anxiety.

Embody Pricing

PlanMonthly CostIncludes
First month$149Meds + metabolic report + 1:1 guidance + 24/7 support
Ongoing (monthly)$299/moMeds + ongoing support + dose adjustments
6-month planDiscountedLower per-month cost for longer commitment

The Oral Tirzepatide Gum: What It Is

Embody's flagship offering is compounded tirzepatide delivered as a chewable gum. The gum is designed to facilitate absorption through the oral tissues, bypassing some of the digestive breakdown that makes oral peptide delivery challenging.

It's important to note that this is a compounded product — not the same as FDA-approved oral tirzepatide (which is still in development by Eli Lilly). Embody's gum is prepared by licensed compounding pharmacies based on individual prescriptions.

They also offer compounded semaglutide in injectable format for patients who prefer the traditional weekly injection.

What's Included Beyond Medication

Personalized Metabolic Report

Embody provides a metabolic report in the first month that analyzes your baseline metabolic markers. This gives you a data-driven starting point for tracking progress — something most providers skip entirely.

1:1 Guidance

The first month includes personalized guidance sessions with a care specialist, covering medication expectations, lifestyle modifications, and treatment planning.

24/7 Support

Round-the-clock access to their care team for questions about dosing, side effects, or progress — included at no extra cost.

Is the $299/Month Ongoing Price Worth It?

This is the key question. Embody's $149 first month is one of the lowest entry points in the market. But at $299/month ongoing, you're paying a significant premium over competitors offering compounded semaglutide at $119–174/month.

The premium is justified if you specifically want oral tirzepatide (very few providers offer this format) or if the metabolic reporting and guided care model appeals to you. It's harder to justify if you're comfortable with injectables and primarily price-sensitive.

How Embody Compares

ProviderStarting PriceOral Option?Details
Get Thin MD$119/moYes (oral tablet)Check Price → Paid link
Embody$149 1st moYes (tirz gum)Check Price → Paid link
Yucca Health$149/moNoCheck Price → Paid link
Novi$174/moNoCheck Price → Paid link
⚠️ Important Distinction
Embody's oral tirzepatide gum is a compounded product — not FDA-approved. It is not the same as FDA-approved oral tirzepatide being developed by Eli Lilly. Compounded oral delivery formats are newer and have less real-world usage data than injectable formulations. Discuss with your clinician whether this format is appropriate for your situation.

Key Takeaways

Compare All GLP-1 Prices

See today's lowest verified prices from vetted telehealth providers.

Compare Prices →
Paid link · Compounded medications are not FDA-approved.